Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 4/20 | 0.51 |
| ▸ | TNKS | O95271 | 2/20 | 0.49 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.49 |
| ▸ | PARP1 | P09874 | 2/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.44 |
| ▸ | TUBB | P07437 | 2/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.44 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.44 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.44 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.44 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.44 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.44 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.44 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.44 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9010817 | 0.99 | GUSB (0.50) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL13953178 | 0.86 | AMY1A (0.57) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL1232936 | 0.84 | TNKS (0.49) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL29351150 | 0.84 | TNKS (0.49) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL23732260 | 0.84 | TNKS (0.57) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL3660038 | 0.83 | TNKS (0.48) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| Ammonia Solution, Strong SCHEMBL9010745 | 0.83 | TNKS (0.48) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL13932609 | 0.82 | TNKS (0.50) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL15964871 | 0.82 | TNKS (0.50) | GUSBTNKSTNKS2PARP1CYP1A1 | |
| SCHEMBL3660037 | 0.81 | GUSB (0.48) | GUSBTNKSTNKS2PARP1CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240044893-A1 | ULTRASENSITIVE SENSING METHOD FOR DETECTION OF BIOMOLECULES | UNIV CONNECTICUT (US) | 2024-02-08 | — | — | US | claimed |
| WO-2024020471-A2 | TOPOGRAPHIC MODULATION OF ENZYMATIC REACTION AFFORDS ULTRASENSITIVE COMPARTMENT-FREE DIGITAL IMMUNOASSAYS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-01-25 | — | — | WO | claimed |
| EP-2972345-B1 | A FLOW-THROUGH CELL COUNTING ASSAY | ALLIED INNOVATIVE SYSTEMS LLC (US) | 2018-01-17 | — | — | EP | claimed |
| EP-2972345-A1 | A FLOW-THROUGH CELL COUNTING ASSAY | Allied Innovative Systems, LLC (US) | 2016-01-20 | — | — | EP | claimed |
| US-9097712-B2 | Flow-through cell counting assay | ALLIED INNOVATIVE SYSTEMS LLC (US) | 2015-08-04 | — | — | US | claimed |
| US-20140349893-A1 | LABELING OF IMMOBILIZED PROTEINS USING DIPYRROMETHENEBORON DIFLUORIDE DYES | Life Technologies Corporation (US) | 2014-11-27 | — | — | US | claimed |
| WO-2014149310-A1 | A FLOW-THROUGH CELL COUNTING ASSAY | ALLIED INNOVATIVE SYSTEMS, LLC (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140273018-A1 | FLOW-THROUGH CELL COUNTING ASSAY | ALLIED INNOVATIVE SYSTEMS, LLC (US) | 2014-09-18 | — | — | US | claimed |
| JP-4643263-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| JP-4643262-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| WO-2004020604-A2 | ALLELE SPECIFIC PRIMER EXTENSION | AMERSHAM BIOSCIENCES CORP (US) | 2004-03-11 | — | — | WO | claimed |
| US-20040048301-A1 | Allele specific primer extension | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2004-03-11 | — | — | US | claimed |
| WO-2004020603-A2 | ANALYTE DETECTION | AMERSHAM BIOSCIENCES CORP (US) | 2004-03-11 | — | — | WO | claimed |
| US-20030162213-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-08-28 | — | — | US | claimed |
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-07-03 | — | — | US | claimed |
| US-20030096253-A1 | Single nucleotide amplification and detection by polymerase | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-05-22 | — | — | US | claimed |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2003-04-24 | — | — | US | claimed |
| WO-2003020984-A2 | TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES AND METHODS OF USE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020734-A2 | LABELED NUCLEOSIDE POLYPHOSPHATES | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
| WO-2003020891-A2 | SINGLE NUCLEOTIDE AMPLIFICATION AND DETECTION BY POLYMERASE | AMERSHAM BIOSCIENCES CORP (US) | 2003-03-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030124576-A1 | Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases | PNP, RNGTT, MTAP | GUSB 396/4885TNKS 1006/4885TNKS2 1317/4885 |
| US-20030077610-A1 | Terminal-phosphate-labeled nucleotides and methods of use | RNGTT, DNTT, PNP | GUSB 288/4885TNKS 429/4885TNKS2 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.